Published in J Watch AIDS Clin Care on March 01, 2010
Micronutrient supplementation in adults with HIV infection. Cochrane Database Syst Rev (2017) 0.75
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2010) 2.25
HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr (2002) 1.97
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med (2012) 1.15
Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. J Womens Health (Larchmt) (2011) 1.15
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS (2011) 1.10
Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count. Antivir Ther (2011) 1.02
Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics (2012) 1.02
HIV health care services for Mexican migrants. J Acquir Immune Defic Syndr (2004) 1.00
Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther (2003) 0.96
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials (2011) 0.89
Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil. Rev Saude Publica (2011) 0.84
Health-related quality of life in the gender, race, and clinical experience trial. AIDS Res Treat (2011) 0.83
Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE). J Acquir Immune Defic Syndr (2014) 0.80
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications. AIDS Patient Care STDS (2003) 0.80
Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol (2011) 0.80
Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey. AIDS Patient Care STDS (2013) 0.79
Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine. AIDS (2014) 0.79
Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa. BMC Infect Dis (2014) 0.78
Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. AIDS Clin Care (2007) 0.77
Cardiovascular risk factors and antiretroviral therapy. N Engl J Med (2003) 0.76
Report from the 11th conference on retroviruses and opportunistic infections. Metabolic complications. AIDS Clin Care (2004) 0.75
Report from the Tenth Retrovirus Conference. Metabolic complications. AIDS Clin Care (2003) 0.75
Report from the 11th conference on retroviruses and opportunistic infections. Neurology of HIV. AIDS Clin Care (2004) 0.75
Top stories of 2004. HAART and the heart. AIDS Clin Care (2005) 0.75
Report from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. AIDS Clin Care (2007) 0.75
Meeting notes from the 3rd IAS Conference. HIV treatment and risk for metabolic complications. AIDS Clin Care (2005) 0.75
Metabolic complications of HIV infection: translating research findings into clinical practice. AIDS Clin Care (2002) 0.75
Meeting report from the XV International AIDS Conference. Metabolic complications. AIDS Clin Care (2004) 0.75
Report from the 13th retrovirus conference. Metabolic complications and cardiovascular disease. AIDS Clin Care (2006) 0.75
Report on the XIV International AIDS Conference. AIDS Clin Care (2002) 0.75
Report from the 7th International Lipodystrophy Meeting. AIDS Clin Care (2006) 0.75